Chemo-Free hope: new pill combo targets Hard-to-Treat breast cancer
NCT ID NCT07716046
First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time
Summary
This study tests whether adding a new oral drug called fulvestaciclib to standard anti-HER2 and hormone therapy can help people with HR+/HER2+ advanced breast cancer live longer without their disease getting worse. Some participants receive the combo after initial chemotherapy, while others get it as a first-line treatment without any chemo. The goal is to find a more effective and less toxic option for this type of breast cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a combination of fulvestaciclib (an oral CDK4/6 inhibitor), trastuzumab, pertuzumab, and an endocrine therapy (fulvestrant, letrozole, or anastrozole)
- What this could lead to
- If successful, this could offer a chemotherapy-free option for people with HR+/HER2+ advanced breast cancer, potentially delaying disease progression and reducing side effects.
- What could go wrong
- This is a phase II trial, so the results are preliminary. The combination may not improve outcomes over standard therapy, and side effects from the drugs could be significant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Chest-Injected drug drain Cancer's fluid trap?
- A dab of gel on the breathing tube might spare surgery patients a sore throat — a trial puts it to the test.
- Can a deeper nerve block ease pain after breast surgery?
- Does breast cancer radiation harm a key immune gland? a study investigates
- A web program may ease the emotional toll of chemotherapy hair loss
- Can a new drug outsmart resistant breast cancer?